ACTEMRA sol inj 162 mg/0.9 ml stylo préremp 4 pce
7680669310011
CH-66931
L04AC07
07.15.0.
Reimbursement limitations:
ACTEMRA6
Le traitement avec Actemra exige une garantie préalable de prise en charge des frais par …
1 / 3
google
Details
- Product number
- 6693101
- CPT
- -
- Packaging group
- 4
- Unit
- Injektor(en), vorgefüllt/Pen
- Composition
- tocilizumabum 162 mg, polysorbatum 80, arginini hydrochloridum, methioninum, histidinum, histidini hydrochloridum monohydricum, aqua ad iniectabile q.s. ad solutionem pro 0.9 ml.
Articles (1)
Actemra 162 mg/0.9 ml, Injektionslösung in einem Fertigpen zur subkutanen Anwendung
Injektionslösung
4
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
(N/A)
|
162.0 MG | Substance | Wirkstoff (Principe actif) |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
|
(N/A)
|
- | Substance | HNIDK |
Reimbursement information
Public price
CHF 1063.70
Specialties list
Yes
Generic
No
Reimbursement limitation
SL addition date:
01/03/2019
Authorization holder
Roche Pharma (Schweiz) AG
4058 Basel
Authorization information
- Swissmedic authorization number
- 66931
- Drug name
- Actemra, Injektionslösung in einem Fertigpen zur subkutanen Anwendung
- Galenic form
- LSPA
- ATC Code
- L04AC07
- Authorization status
- Z
- Dispensation category
- A
- First authorization
- 10/12/2018
- Authorization expiration date
- 31/12/9999
- IT number
- 07.15.0.
- Domain
- Human medicine
Packaging details
- Description (FR)
- ACTEMRA sol inj 162 mg/0.9 ml stylo préremp 4 pce
- Description (DE)
- ACTEMRA Inj Lös 162 mg/0.9 ml Fertigpen 4 Stk
- Market launch
- 10/12/2018
- Narcotic (BTM)
- No